Item 5. Market for Registrant’s Common Equity
Item
5. Market for Company’s Common Equity, Related Stockholder Matters and Small Business Issuer Purchases of Equity Securities
Market
Information
From
February 1, 2022 until the completion of the business combination, the principal market on which our unit was traded is the Nasdaq Capital
Market. Our common share, warrant and right traded on the Nasdaq from March 24, 2022 until the completion of the business combination.
The Company’s unit was trading under the symbol “ACAXU,” common stock was traded under symbol “ACAX,” our
warrant was traded under the symbol “ACAXW,” and the right was traded under the symbol “ACAXR.” Subsequent to
the completion of the business combination, our common stock has traded on the Nasdaq under the symbol “HWH”.
Prior
to our listing on the Nasdaq Capital Market there was no public trading market for our securities.
Holders
As
of February 28, 2024, the Company had five stockholders of record.
Dividends
Since
inception we have not paid any dividends on our common stock. We currently do not anticipate paying any cash dividends in the foreseeable
future on our common stock. Although we intend to retain our earnings, if any, to finance the exploration and growth of our business,
our board of directors will have the discretion to declare and pay dividends in the future. Payment of dividends in the future will depend
upon our earnings, capital requirements, and other factors, which our board of directors may deem relevant.
Securities
authorized for issuance under equity compensation plans.
The
Company does not have securities authorized for issuance under any equity compensation plans
Performance
graph
Not
applicable to smaller reporting companies.
Recent
sales of unregistered securities; use of proceeds from registered securities
On
November 8, 2021, our Sponsor purchased 2,156,250 founder shares for an aggregate purchase price of $25,000, or approximately $0.012
per share. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Prior to the initial investment in the company of $25,000 by our Sponsor, the Company had no assets, tangible or intangible. The per
share purchase price of the founder shares was determined by dividing the amount of cash contributed to the Company by the aggregate
number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares
would represent 20% of the outstanding shares after the Initial Public Offering (excluding the placement units and underlying securities).
On
February 3, 2022, we consummated our Initial Public Offering (the “Offering”) of an aggregate of 8,625,000 units (“Units”)
including the issuance of 1,125,000 Units as a result of the underwriter’s full exercise of its over-allotment option. The Units
were sold at an offering price of $10.00 per Unit, generating gross proceeds of $86,250,000.
11
Simultaneously
with the consummation of the Offering, the Company consummated the private placement of 473,750 units (the “Private Placement Units”)
to the Sponsor, including the issuance of 33,750 Private Placement Units in connection with the underwriter’s full exercise of
its over-allotment option, at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $4,735,500 (the “Private
Placement”). The Private Placement was conducted as a non-public transaction and, as a transaction by an issuer not involving a
public offering, is exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act.
Of
the gross proceeds received from the Offering, including the full exercise of the over-allotment option, and the Private Placement Units,
$86.25 million and $4.7 million was placed in the Trust Account, respectively.
On
February 3, 2022, the Company paid a cash underwriting discount of $0.20 per Unit, or $1,725,000. In addition, the underwriters are entitled
to a deferred fee of $0.35 per Unit, or $3,018,750 in the aggregate. The deferred fee will become payable to the underwriters from the
amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the
underwriting agreement.
On
December 18, 2023, the Company entered into a Satisfaction and Discharge of Indebtedness Agreement (the “Satisfaction Agreement”)
in connection with the Underwriting Agreement, dated January 31, 2022 (the “Underwriting Agreement”), with EF Hutton, LLC
(“EF Hutton”), in which pursuant to that certain Underwriting Agreement the Company was due to pay $3,018,750 to EF Hutton
as deferred underwriting commission (the “Deferred Underwriting Commission”) upon the closing of the business combination.
In lieu of the Company tendering the full amount of Deferred Underwriting Commission, the Company and EF Hutton entered into the Satisfaction
Agreement, pursuant to which EF Hutton will accept a combination of $325,000 in cash (the “Cash Payment”) upon the closing
of the business combination, 149,443 shares of the Company’s common stock (the “Shares”) and a $1,184,375 promissory
note (the “Promissory Note”) as full satisfaction of the Deferred Underwriting Commission. Satisfaction and discharge of
the Deferred Underwriting Commission is dependent on the Company’s delivery of the Cash Payment, the Shares and the Promissory
Note under the terms of the Satisfaction Agreement. Additionally, the Company has granted EF Hutton an irrevocable right of first refusal
(the “ROFR”) to act as the sole investment banker, sole book-runner, and/or sole placement agent, at EF Hutton’s sole
discretion, for each and every future public and private equity and debt offering, including all equity linked financing for a period
commencing on the date of the satisfaction and ending twenty-four (24) months after the closing of the business combination.
Purchases
of Equity Securities by the issuer and affiliated purchasers
The
Company did not repurchase any shares of the Company’s common stock during 2023 and 2022.
Item 6. [RESERVED]
Not required for smaller reporting companies.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.